Those With Asthma Not at Greater Risk for Severe Disease from COVID-19

Translate to Spanish or other 102 languages!

“Research over the past two years has shown that, contrary to early opinion, asthma doesn’t seem to make COVID-19 more severe or deadly for those who suffer from the disease,” says Mark Corbett, MD, president of the American College of Allergy, Asthma and Immunology (ACAAI). Image for Illustration Purposes
“Research over the past two years has shown that, contrary to early opinion, asthma doesn’t seem to make COVID-19 more severe or deadly for those who suffer from the disease,” says Mark Corbett, MD, president of the American College of Allergy, Asthma and Immunology (ACAAI). Image for Illustration Purposes

Mega Doctor News

- Advertisement -

By American College of Allergy, Asthma and Immunology (ACAAI)

Newswise — ARLINGTON HEIGHTS, Illinois – From the beginning of the COVID-19 pandemic, health experts were concerned that people with asthma would not only be more likely to contract the virus, but they would also be more severely affected by the respiratory nature of the disease. They thought due to the way coronavirus attacks, people with asthma would have worse illness.

“Research over the past two years has shown that, contrary to early opinion, asthma doesn’t seem to make COVID-19 more severe or deadly for those who suffer from the disease,” says Mark Corbett, MD, president of the American College of Allergy, Asthma and Immunology (ACAAI). “We’ve been relieved to see over the past several years that our patients whose asthma is well controlled don’t seem to be getting COVID-19 at a higher rate or suffering from it more severely.”

- Advertisement -

May is Asthma and Allergy Awareness Month, a time to shine a spotlight on asthma and allergies, along with the latest news and important developments. Many people don’t know that allergists are experts in treating asthma, and that allergies and asthma are closely linked. Allergists are specialists who can help get asthma symptoms under control.

“We’ve had more than 20 studies submitted to our journal in the last two years that examine the relationship between asthma, and the rate and severity of COVID-19 infection,” says Mitchell Grayson, MD, Editor-in-Chief of Annals of Allergy, Asthma and Immunology, ACAAI’s scientific journal. A recent Annals study from the Washington University School of Medicine in St. Louis, MO, examined 435 patients suspected of having COVID-19. “The results showed those with asthma were more likely to test negative for COVID-19 than those without asthma,” says Dr. Grayson. “And while it’s true that patients with asthma face challenges in differentiating between symptoms of COVID-19 and other respiratory infections and routine asthma exacerbations, the studies are showing us that asthma patients aren’t more likely to get severe disease if they do get COVID-19.”

“Especially as we continue to battle COVID-19, anyone with asthma should be aware that they need to protect themselves from all types of respiratory infections, including those caused by the flu,” says Dr. Corbett. “As we move into spring and the flu may be on the wane, asthma sufferers still need to do whatever they can to keep symptoms under control. As allergists, we see patients every day who think their asthma is controlled, when it actually is not. This is not a time when anyone with asthma symptoms wants to land in the hospital. Your allergist can create a plan tailored to you, to help keep you healthy and living your best life.”According to the ACAAI publication Asthma Management and the Allergist: Better Outcomes at Lower Cost, asthma care provided by allergists is associated with better patient outcomes across a range of important markers. Compared to care provided by generalists, patients getting care from an allergist have fewer hospitalizations and emergency room visits, higher ratings for the quality of care, fewer restrictions in activities and improved physical functioning. For more information about treatment of asthma, and to locate an allergist 

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

What Persistent Fatigue Might Be Telling You

Mega Doctor News CLEVELAND CLINIC - We’ve all had those days where we’re...

AMA Unveils New Initiative to Boost Nutrition Education Nationwide

The American Medical Association (AMA) is launching a nutrition education initiative to equip physicians and medical students with practical, evidence-based knowledge and tools to help patients live healthier lives.

DHR Health to Host Headache Symposium to Address Gap in Neurological Care, March 28th

In the United States, headaches remain a common health concern, affecting approximately one in six Americans. Migraines, a type of headache, are the second leading cause of years lived with disability nationwide.

Study Finds GLP‑1 Therapy Reduces Heart and Kidney Risks for Type 1 Diabetes Patients

People with type 1 diabetes who took GLP-1 receptor agonist (GLP-1-RA) drugs for weight loss or better blood-sugar control had significantly reduced risks of major cardiovascular events and end-stage kidney disease without any increase in safety concerns, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.
- Advertisement -